Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd (603707.SS)
CNY 10.15
(-1.36%)
CNY 10.15
(-1.36%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -0.12 CNY | -117.65% |
| 2022 | 0.68 CNY | 1.49% |
| 2021 | 0.67 CNY | 31.37% |
| 2020 | 0.51 CNY | 34.21% |
| 2019 | 0.38 CNY | 8.57% |
| 2018 | 0.35 CNY | 66.67% |
| 2017 | 0.21 CNY | 10.53% |
| 2016 | 0.19 CNY | 126.19% |
| 2015 | 0.08 CNY | 71.43% |
| 2014 | 0.05 CNY | -30.0% |
| 2013 | 0.07 CNY | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | 0.14 CNY | 27.27% |
| 2024 Q3 | 0.12 CNY | -14.29% |
| 2024 Q1 | 0.11 CNY | 117.19% |
| 2023 Q2 | 0.18 CNY | -14.29% |
| 2023 Q1 | 0.21 CNY | 90.91% |
| 2023 FY | - CNY | -117.65% |
| 2023 Q4 | -0.64 CNY | -592.31% |
| 2023 Q3 | 0.13 CNY | -27.78% |
| 2022 Q1 | 0.27 CNY | 107.69% |
| 2022 FY | - CNY | 1.49% |
| 2022 Q2 | 0.23 CNY | -14.81% |
| 2022 Q4 | 0.11 CNY | -54.17% |
| 2022 Q3 | 0.24 CNY | 4.35% |
| 2021 Q4 | 0.13 CNY | -45.83% |
| 2021 Q1 | 0.22 CNY | 37.5% |
| 2021 Q2 | 0.23 CNY | 4.55% |
| 2021 FY | - CNY | 31.37% |
| 2021 Q3 | 0.24 CNY | 4.35% |
| 2020 Q1 | 0.17 CNY | 30.77% |
| 2020 FY | - CNY | 34.21% |
| 2020 Q2 | 0.17 CNY | 0.0% |
| 2020 Q3 | 0.13 CNY | -23.53% |
| 2020 Q4 | 0.16 CNY | 23.08% |
| 2019 Q1 | 0.12 CNY | 62.16% |
| 2019 FY | - CNY | 8.57% |
| 2019 Q4 | 0.13 CNY | 30.0% |
| 2019 Q3 | 0.10 CNY | -16.67% |
| 2019 Q2 | 0.12 CNY | 0.0% |
| 2018 Q2 | 0.09 CNY | 12.66% |
| 2018 Q3 | 0.07 CNY | -22.02% |
| 2018 Q1 | 0.08 CNY | -1.78% |
| 2018 Q4 | 0.07 CNY | 8.82% |
| 2018 FY | - CNY | 66.67% |
| 2017 Q2 | 0.07 CNY | 102.17% |
| 2017 Q3 | 0.07 CNY | 5.36% |
| 2017 Q4 | 0.08 CNY | 14.53% |
| 2017 FY | - CNY | 10.53% |
| 2017 Q1 | 0.03 CNY | -36.54% |
| 2016 Q3 | 0.01 CNY | -91.13% |
| 2016 Q2 | 0.15 CNY | 588.07% |
| 2016 Q1 | 0.02 CNY | 0.0% |
| 2016 Q4 | 0.05 CNY | 282.71% |
| 2016 FY | - CNY | 126.19% |
| 2015 FY | - CNY | 71.43% |
| 2014 FY | - CNY | -30.0% |
| 2013 FY | - CNY | 0.0% |